日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

心脏声学生物标志物在监测心力衰竭患者中的作用:系统性文献综述

Butler, Javed; Brown, Malcolm; Prokocimer, Philippe; Humphries, Ashley C; Pope, Sophie; Wright, Olivia; Su, Jun; Elnawasany, Osama; Muresan, Bogdan

Antimicrobial Effect of Zn2+ Ions Governs the Microbial Quality of Donor Human Milk

Zn2+ 离子的抗菌作用决定了供体母乳的微生物质量

Carmel Hutchings, Zafnat Prokocimer Yair, Ram Reifen, Moshe Shemesh

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials

制定共识性临床终点,以评估未来医院获得性/呼吸机相关性细菌性肺炎临床试验中抗菌治疗的疗效

Weiss, Emmanuel; Zahar, Jean-Ralph; Alder, Jeff; Asehnoune, Karim; Bassetti, Matteo; Bonten, Marc J M; Chastre, Jean; De Waele, Jan; Dimopoulos, George; Eggimann, Philippe; Engelhardt, Marc; Ewig, Santiago; Kollef, Marin; Lipman, Jeffrey; Luna, Carlos; Martin-Loeches, Ignacio; Pagani, Leonardo; Palmer, Lucy B; Papazian, Laurent; Poulakou, Garyphallia; Prokocimer, Philippe; Rello, Jordi; Rex, John H; Shorr, Andrew F; Talbot, George H; Thamlikitkul, Visanu; Torres, Antoni; Wunderink, Richard G; Timsit, Jean-François

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials

特地唑胺和利奈唑胺治疗注射吸毒者急性细菌性皮肤及皮肤结构感染的疗效和安全性:两项临床试验的分析

Moran, Gregory J; De Anda, Carisa; Das, Anita F; Green, Sinikka; Mehra, Purvi; Prokocimer, Philippe

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers

在健康志愿者中单独或联合使用替地唑胺和伪麻黄碱的药代动力学研究

Flanagan, Shawn; Minassian, Sonia L; Prokocimer, Philippe

Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials

基于两项3期双盲试验的汇总分析,按严重程度指标评估特地唑胺与利奈唑胺治疗急性细菌性皮肤及皮肤结构感染的临床疗效

Sandison, Taylor; De Anda, Carisa; Fang, Edward; Das, Anita F; Prokocimer, Philippe

Reduction in Tedizolid Plasma Exposure among End-Stage Renal Disease Patients Undergoing Dialysis Is Explained by Variations in Ideal Body Weight

终末期肾病透析患者血浆中替地唑胺暴露量的降低可由理想体重的变化来解释。

Flanagan, Shawn; Prokocimer, Philippe

Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

特地唑利(一种新型抗生素)在拉丁裔急性细菌性皮肤及皮肤结构感染患者中的疗效、安全性、耐受性和群体药代动力学研究

Ortiz-Covarrubias, Alejandro; Fang, Edward; Prokocimer, Philippe G; Flanagan, Shawn D; Zhu, Xu; Cabré-Márquez, Jose Francisco; Tanaka, Toshiaki; Passarell, Julie; Fiedler-Kelly, Jill; Nannini, Esteban C

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

对特地唑胺与利奈唑胺治疗急性细菌性皮肤及皮肤结构感染的3期ESTABLISH试验进行分析

Shorr, Andrew F; Lodise, Thomas P; Corey, G Ralph; De Anda, Carisa; Fang, Edward; Das, Anita F; Prokocimer, Philippe

Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials

接受替地唑胺或利奈唑胺治疗的急性细菌性皮肤及皮肤结构感染患者的血小板谱:来自3期ESTABLISH临床试验的结果

Lodise, Thomas P; Fang, Edward; Minassian, Sonia L; Prokocimer, Philippe G